Daclizumab to Treat Wegener's Granulomatosis
Clinical trial NCT00040248 · COMPLETED
Trial details
- NCT number
- NCT00040248
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-06-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.